To explore the influence of the relationship between GUSBP11 and miR-605-3p on CRC cells, it was validated by co-transfecting si-GUSBP11 and miR inhibitors into the HCT116 cell lines. The gene discussed is GUSBP11; the disease is colorectal carcinoma.